G Sotgiu1, S Rosales-Klintz2, R Centis3, L D'Ambrosio4, R Verduin5, A M Correia6, A Cirule7, R Duarte8, B Gadzheva9, G Gualano10, H Kunst11, F Palmieri10, V Riekstina7, D Stefanova12, S Tiberi13, M J van der Werf2, G B Migliori3. 1. Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy. 2. European Centre for Disease Prevention and Control, Stockholm, Sweden. 3. Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Tradate, Italy. 4. Public Health Consulting Group, Lugano, Switzerland. 5. Verduin Public Health Consult, Oegstgeest, the Netherlands. 6. Regional Health Administration of the North, Department of Public Health, Porto, Portugal. 7. Centre of TB and Lung Diseases, Riga East University Hospital, Riga, Latvia. 8. National Reference Centre for MDR-TB, Hospital Centre Vila Nova de Gaia, Department of Pneumology; Public Health Science and Medical Education Department, Faculty of Medicine, University of Porto, Porto, Portugal. 9. The Global Fund to fight AIDS, Tuberculosis and Malaria (GFATM) Programme, Department of Management of Specialized Donor-Funded Programmes, Ministry of Health, Sofia, Bulgaria. 10. Respiratory Infectious Diseases Unit, L Spallanzani National Institute for Infectious Diseases, IRCCS, Rome, Italy. 11. Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University, London, UK. 12. St Sofia University Hospital for Active Treatment of Respiratory Diseases, Sofia, Bulgaria. 13. Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University, London, UK, Division of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK.
Abstract
BACKGROUND: Essential TB care in the European Union/European Economic Area (EU/EEA) comprises 21 standards for the diagnosis, treatment and prevention of TB that constitute the European Union Standards for Tuberculosis Care (ESTC). METHODS: In 2017, we conducted an audit on TB management and infection control measures against the ESTC standards. TB reference centres in five EU/EEA countries were purposely selected to represent the heterogeneous European TB burden and examine geographic variability. RESULTS: Data from 122 patients, diagnosed between 2012 and 2015 with multidrug-resistant TB (n = 49), extensively drug-resistant TB (XDR-TB) (n = 11), pre-XDR-TB (n = 29) and drug-susceptible TB (n = 33), showed that TB diagnosis and treatment practices were in general in agreement with the ESTC. CONCLUSION: Overall, TB management and infection control practices were in agreement with the ESTC in the selected EU/EEA reference centres. Areas for improvement include strengthening of integrated care services and further implementation of patient-centred approaches.
BACKGROUND: Essential TB care in the European Union/European Economic Area (EU/EEA) comprises 21 standards for the diagnosis, treatment and prevention of TB that constitute the European Union Standards for Tuberculosis Care (ESTC). METHODS: In 2017, we conducted an audit on TB management and infection control measures against the ESTC standards. TB reference centres in five EU/EEA countries were purposely selected to represent the heterogeneous European TB burden and examine geographic variability. RESULTS: Data from 122 patients, diagnosed between 2012 and 2015 with multidrug-resistant TB (n = 49), extensively drug-resistant TB (XDR-TB) (n = 11), pre-XDR-TB (n = 29) and drug-susceptible TB (n = 33), showed that TB diagnosis and treatment practices were in general in agreement with the ESTC. CONCLUSION: Overall, TB management and infection control practices were in agreement with the ESTC in the selected EU/EEA reference centres. Areas for improvement include strengthening of integrated care services and further implementation of patient-centred approaches.
Authors: Marieke J van der Werf; Andreas Sandgren; Lia D'Ambrosio; Francesco Blasi; Giovanni Battista Migliori Journal: Eur Respir J Date: 2014-04 Impact factor: 16.671
Authors: Giovanni Sotgiu; Payam Nahid; Robert Loddenkemper; Ibrahim Abubakar; Marc Miravitlles; Giovanni Battista Migliori Journal: Eur Respir J Date: 2016-09-01 Impact factor: 16.671
Authors: Giovanni Battista Migliori; Giovanni Sotgiu; Senia Rosales-Klintz; Rosella Centis; Lia D'Ambrosio; Ibrahim Abubakar; Graham Bothamley; Jose Antonio Caminero; Daniela Maria Cirillo; Masoud Dara; Gerard de Vries; Stefano Aliberti; Anh Tuan Dinh-Xuan; Raquel Duarte; Fabio Midulla; Ivan Solovic; Dragan R Subotic; Massimo Amicosante; Ana Maria Correia; Andra Cirule; Gina Gualano; Heinke Kunst; Fabrizio Palmieri; Vija Riekstina; Simon Tiberi; Remi Verduin; Marieke J van der Werf Journal: Eur Respir J Date: 2018-05-17 Impact factor: 16.671
Authors: G B Migliori; G Sotgiu; L D'Ambrosio; R Centis; C Lange; G Bothamley; D M Cirillo; S De Lorenzo; G Guenther; K Kliiman; R Muetterlein; V Spinu; M Villar; J P Zellweger; A Sandgren; E Huitric; D Manissero Journal: Eur Respir J Date: 2012-02-09 Impact factor: 16.671
Authors: Payam Nahid; Susan E Dorman; Narges Alipanah; Pennan M Barry; Jan L Brozek; Adithya Cattamanchi; Lelia H Chaisson; Richard E Chaisson; Charles L Daley; Malgosia Grzemska; Julie M Higashi; Christine S Ho; Philip C Hopewell; Salmaan A Keshavjee; Christian Lienhardt; Richard Menzies; Cynthia Merrifield; Masahiro Narita; Rick O'Brien; Charles A Peloquin; Ann Raftery; Jussi Saukkonen; H Simon Schaaf; Giovanni Sotgiu; Jeffrey R Starke; Giovanni Battista Migliori; Andrew Vernon Journal: Clin Infect Dis Date: 2016-08-10 Impact factor: 9.079
Authors: Knut Lönnroth; Giovanni Battista Migliori; Ibrahim Abubakar; Lia D'Ambrosio; Gerard de Vries; Roland Diel; Paul Douglas; Dennis Falzon; Marc-Andre Gaudreau; Delia Goletti; Edilberto R González Ochoa; Philip LoBue; Alberto Matteelli; Howard Njoo; Ivan Solovic; Alistair Story; Tamara Tayeb; Marieke J van der Werf; Diana Weil; Jean-Pierre Zellweger; Mohamed Abdel Aziz; Mohamed R M Al Lawati; Stefano Aliberti; Wouter Arrazola de Oñate; Draurio Barreira; Vineet Bhatia; Francesco Blasi; Amy Bloom; Judith Bruchfeld; Francesco Castelli; Rosella Centis; Daniel Chemtob; Daniela M Cirillo; Alberto Colorado; Andrei Dadu; Ulf R Dahle; Laura De Paoli; Hannah M Dias; Raquel Duarte; Lanfranco Fattorini; Mina Gaga; Haileyesus Getahun; Philippe Glaziou; Lasha Goguadze; Mirtha Del Granado; Walter Haas; Asko Järvinen; Geun-Yong Kwon; Davide Mosca; Payam Nahid; Nobuyuki Nishikiori; Isabel Noguer; Joan O'Donnell; Analita Pace-Asciak; Maria G Pompa; Gilda G Popescu; Carlos Robalo Cordeiro; Karin Rønning; Morten Ruhwald; Jean-Paul Sculier; Aleksandar Simunović; Alison Smith-Palmer; Giovanni Sotgiu; Giorgia Sulis; Carlos A Torres-Duque; Kazunori Umeki; Mukund Uplekar; Catharina van Weezenbeek; Tuula Vasankari; Robert J Vitillo; Constantia Voniatis; Maryse Wanlin; Mario C Raviglione Journal: Eur Respir J Date: 2015-04 Impact factor: 16.671
Authors: Gerard de Vries; Svetla Tsolova; Laura F Anderson; Agnes C Gebhard; Einar Heldal; Vahur Hollo; Laura Sánchez-Cambronero Cejudo; Daniela Schmid; Bert Schreuder; Tonka Varleva; Marieke J van der Werf Journal: BMC Public Health Date: 2017-04-19 Impact factor: 3.295
Authors: Karina Kielmann; Nicole Vidal; Vija Riekstina; Maria Krutikov; Marieke J van der Werf; Evita Biraua; Predrag Duric; David A J Moore Journal: PLoS One Date: 2018-10-17 Impact factor: 3.240